|
Showing the most relevant articles for your search:NASDAQ:KITE | 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 | | 2017/10/14 | 06 : 05 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:KITE | Kite Pharma, Inc. |
| 2017/10/06 | 04 : 44 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:KITE | Kite Pharma, Inc. |
| 2017/10/04 | 06 : 12 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:KITE | Kite Pharma, Inc. |
| 2017/10/04 | 06 : 07 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:KITE | Kite Pharma, Inc. |
| 2017/10/04 | 06 : 02 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:KITE | Kite Pharma, Inc. |
| 2017/10/04 | 05 : 57 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:KITE | Kite Pharma, Inc. |
| 2017/10/04 | 05 : 56 | Edgar (US Regulatory) | Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr) | NASDAQ:KITE | Kite Pharma, Inc. |
| 2017/10/04 | 05 : 44 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:KITE | Kite Pharma, Inc. |
| 2017/10/03 | 22 : 03 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:KITE | Kite Pharma, Inc. |
| 2017/10/03 | 21 : 46 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:KITE | Kite Pharma, Inc. |
| 2017/10/03 | 21 : 45 | Business Wire | Gilead Sciences Completes Acquisition of Kite Pharma, Inc. | NASDAQ:KITE | Kite Pharma, Inc. |
| 2017/10/03 | 21 : 17 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:KITE | Kite Pharma, Inc. |
| 2017/10/03 | 21 : 00 | Business Wire | Gilead Sciences Completes Tender Offer for All Outstanding Shares of Kite Pharma, Inc. | NASDAQ:KITE | Kite Pharma, Inc. |
| 2017/09/26 | 21 : 54 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:KITE | Kite Pharma, Inc. |
| 2017/09/26 | 21 : 40 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:KITE | Kite Pharma, Inc. |
| 2017/09/26 | 21 : 30 | Business Wire | Gilead Sciences and Kite Pharma Announce Expiration of Hart-Scott-Rodino Waiting Period | NASDAQ:KITE | Kite Pharma, Inc. |
| 2017/09/26 | 06 : 17 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:KITE | Kite Pharma, Inc. |
| 2017/09/26 | 06 : 13 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:KITE | Kite Pharma, Inc. |
| 2017/09/26 | 05 : 31 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:KITE | Kite Pharma, Inc. |
| 2017/09/23 | 05 : 18 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:KITE | Kite Pharma, Inc. |
| 2017/09/19 | 06 : 29 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:KITE | Kite Pharma, Inc. |
| 2017/09/16 | 05 : 52 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:KITE | Kite Pharma, Inc. |
| 2017/09/09 | 06 : 30 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:KITE | Kite Pharma, Inc. |
| 2017/09/09 | 06 : 24 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:KITE | Kite Pharma, Inc. |
| 2017/09/09 | 02 : 37 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:KITE | Kite Pharma, Inc. |
| 2017/09/08 | 05 : 12 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:KITE | Kite Pharma, Inc. |
| 2017/09/06 | 05 : 13 | Edgar (US Regulatory) | Statement of Ownership: Solicitation (sc 14d9) | NASDAQ:KITE | Kite Pharma, Inc. |
| 2017/09/06 | 05 : 09 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:KITE | Kite Pharma, Inc. |
| 2017/09/06 | 01 : 24 | Edgar (US Regulatory) | Tender Offer Statement by Third Party (sc To-t) | NASDAQ:KITE | Kite Pharma, Inc. |
| 2017/09/02 | 06 : 28 | Edgar (US Regulatory) | Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c) | NASDAQ:KITE | Kite Pharma, Inc. |
|
Showing the most relevant articles for your search:NASDAQ:KITE |
|